About Avstera Therapeutics
Avstera Therapeutics is a private company based in Malvern, Pennsylvania, incorporated in 2020 in Delaware. It has reported $8,600,000 raised in three offerings on Form D since August 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 19, 2023 | Oct 3, 2023 | $5,000,000fully sold | 1 | $5.0M | EquityRule 506(b) | Form D ↗ |
| May 6, 2022 | May 20, 2022 | $3,500,000of $6.0M target | 3 | $1.1M | Equity, OptionsRule 506(b) | Form D ↗ |
| Jul 21, 2021 | Aug 12, 2021 | $100,000target not set | 1 | $100K | OptionsRule 506(b) | Form D ↗ |
| Total, three offerings | $8,600,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Avstera Therapeutics's Form D filed Oct 3, 2023.
AR
Ajay Raju
Co-Founder and Director
Earlier filings also listed Karthik Musunuri (executive officer, last listed May 2022).